about
Type 1 iodothyronine deiodinase in human physiology and disease: Deiodinases: the balance of thyroid hormoneThe rare intracellular RET mutation p.Ser891Ala in an apparently sporadic medullary thyroid carcinoma: a case report and review of the literatureMolecular basis of medullary thyroid carcinoma: the role of RET polymorphismsACE and PC-1 gene polymorphisms in normoalbuminuric Type 1 diabetic patients: a 10-year prospective studyIncreased type 3 deiodinase expression in papillary thyroid carcinomaRole of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytomaThe rs225017 polymorphism in the 3'UTR of the human DIO2 gene is associated with increased insulin resistanceType 2 iodothyronine deiodinase levels are higher in slow-twitch than fast-twitch mouse skeletal muscle and are increased in hypothyroidism.Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humansN-acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction: a randomized clinical trialDiagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.Effect of 3'UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma.Adaptive activation of thyroid hormone and energy expenditure.Fungal thyroiditis: an overview.Type 2 iodothyronine deiodinase is highly expressed in medullary thyroid carcinoma.Advanced medullary thyroid cancer: pathophysiology and managementIncreasing the radioiodine dose does not improve cure rates in severe graves' hyperthyroidism: a clinical trial with historical control.Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature.The role of thyroid hormone in testicular development and function.Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer.Is there a role for thyroid hormone on spermatogenesis?Reduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma.Is there a role for inherited TRβ mutation in human carcinogenesis? [corrected].The Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus.MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics.MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma.Advances and controversies in the management of medullary thyroid carcinoma.Role of Postoperative Stimulated Thyroglobulin as Prognostic Factor for Differentiated Thyroid Cancer in Children and Adolescents.Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.Type 2 iodothyronine selenodeiodinase is expressed throughout the mouse skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation.Low Recurrence Rates in a Cohort of Differentiated Thyroid Carcinoma Patients: A Referral Center Experience.Sodium selenite supplementation does not fully restore oxidative stress-induced deiodinase dysfunction: Implications for the nonthyroidal illness syndrome.New Insights toward the Acute Non-Thyroidal Illness Syndrome.Invasive fungal infections in endogenous Cushing's syndrome.Clinical and oncological features of children and young adults with multiple endocrine neoplasia type 2A.Lack of association between the type 2 deiodinase A/G polymorphism and hypertensive traits: the Framingham Heart Study.Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study.The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.Fatty acid composition of serum lipid fractions in type 2 diabetic patients with microalbuminuria.
P50
Q22305979-0AD6B2D1-8E08-46EF-81D0-8E79FE11B8B8Q26827963-FFEBF5FF-E2D9-4AE1-86A4-9F75D89E5F86Q27010044-C519223C-6FAF-42B9-8096-5D2EB2894A25Q28215222-249A850B-B58E-4C6D-B873-8CAC538AFC66Q28271602-99EE5E8B-026D-4305-883D-807E7B09958BQ33580374-C8C9758B-9525-41D1-8337-2B30605D2D6EQ34020291-4B54B620-466D-4304-9C05-0B9F51B10AA9Q34392574-ADB37F8A-CC02-4706-BBA5-9C50B004E742Q34446531-94C2799B-9461-43CC-BDE6-0368A41644F8Q34628326-418A4556-2C25-4A7C-9CCD-27181A9D609CQ35396089-93CAEAB0-C7D4-44A1-B865-C389B806C610Q35909900-69DEF527-ECDD-4CD3-92DB-4B0B2AAF8AFAQ36311626-D01148BE-18F2-41D8-982D-1711012313B9Q36398190-9CA5E3A2-65EB-4ABD-BE1A-5F5805059497Q36857216-76688E5E-B9CC-4275-9D3B-1D1955C497C3Q36857218-DE51CCDE-0A57-48CD-B5AC-558B3973AB2FQ37105188-2E46E42B-E643-4708-8EB6-7A224A9F6613Q37225664-97E5AA00-9DFB-4CB0-8E54-2FA5A1F6A3FBQ37252597-7A2521D6-1C06-40D9-A0C5-518570E8A50AQ37387829-F6618163-9F3B-42BC-A687-15E9A7AD4039Q37564331-2D5AB4C6-A73D-4AA3-9324-1228579DD9F8Q37574813-C0C8EB4E-ECFD-4800-8EF7-EFA72BC82DDFQ37998339-7BE749E7-2564-4167-B202-71731D0AED10Q38107399-2782E9AD-ABA3-4D24-A2DC-FABEB2312D2FQ38119437-CC34EDB8-E3C4-4D83-8FE7-A9B3B873F85FQ38752145-6423C45E-7A73-4679-940B-02183958BFC3Q38798153-BECF38BE-D90E-4510-8487-96B4E48E7C4BQ38803080-3D61ECE3-A8AC-4307-A47A-4EFB5D72358AQ38908740-86E14397-3642-42DD-AB77-D97AC4F54A92Q39465913-46BF9278-8ADD-4111-993C-7AC91AAFAA43Q40506525-D50051E8-88BE-4014-B285-F5817659D7C2Q40849366-AEEAE11E-4DE7-4409-BE71-ED9A279B62F5Q41602015-6399BAD6-C498-4B40-BDF2-06C2A3EFB04AQ41822332-4A315A6F-F896-402C-B002-B9FBABC871A5Q41873071-B21F88BB-B7A1-4FA8-9673-28814EFEB14FQ42444529-075C2866-6ABD-4ECC-8A5F-DA940E5E7F9FQ42560078-86BCC066-310D-476E-B700-B4E89891D1A6Q42655520-5C27D0C3-FCA6-4017-AA1C-C98867AAFDA9Q43705584-45DCE269-F8D4-4F51-9A60-D8C5D7854BC0Q44333397-7DDFBA41-8732-4233-91D7-A86AF4266893
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ana Luiza Maia
@ast
Ana Luiza Maia
@en
Ana Luiza Maia
@es
Ana Luiza Maia
@nl
type
label
Ana Luiza Maia
@ast
Ana Luiza Maia
@en
Ana Luiza Maia
@es
Ana Luiza Maia
@nl
prefLabel
Ana Luiza Maia
@ast
Ana Luiza Maia
@en
Ana Luiza Maia
@es
Ana Luiza Maia
@nl
P106
P21
P31
P496
0000-0002-4186-5532